Crinetics Pharmaceuticals
San Diego · Founded 2008
About Crinetics Pharmaceuticals
Crinetics Pharmaceuticals discovers and develops novel therapeutics targeting peptide hormone receptors for the treatment of endocrine-related diseases and cancers. Their programs are derived from internal discovery efforts and use objective hormonal biomarker endpoints for preclinical and clinical studies to reduce both the risk and cost to achieve meaningful clinical data. Crinetics is seeking motivated partners to help advance Their programs to become commercially successful products.
Company Facts
- Founded: 2008
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 501 – 1,000
- Estimated revenue: Less than $1M
- Total funding: $2.0B
- Funding stage: IPO
- Last round: Post-IPO Equity (Jan 2026)
- Ticker: nasdaq:CRNX
- Website: crinetics.com
- Phone: +1 760-274-6963
Industries & Categories
Biotechnology, Health Care, Pharmaceutical, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/crinetics-pharmaceuticals-53996 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.